retatrutide phase 2 obesity trial Severe Shows 30% Weight Loss retatrutide phase 2 trial obesity

An increase in IIEF-EF score (e.g., from moderate ED range into mild or normal range) indicates improvement

Normally, only about 10 percent of hair follicles are in the telogen phase, but during TE, that can jump to 40 percent, says Jodi LoGerfo, DNP, a hair-loss specialist

Semaglutide at a dose of 2.4 mg achieved ~17% reduction

Effective dosing for most users ranges from 0.25mg to 0.5mg daily during loading phases, with underdosing below 0.2mg being the most common cause of perceived non-response

Even so, several studies suggest a tendency toward reduced craving or cue-related food motivation during GLP-1RA treatment, although the magnitude, durability, and specificity of these effects vary across measures, populations, and study designs